Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha - Investments

Research · Analysis · Insights

Zumedha - Investments

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
Close

Search

Zumedha - Investments

Research · Analysis · Insights

Zumedha - Investments

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
Close

Search

Home/Banking & Finance/HDFC Bank (NSE: HDFCBANK) — Stock Analysis April 2026
Banking & Finance

HDFC Bank (NSE: HDFCBANK) — Stock Analysis April 2026

April 7, 2026 7 Min Read
Updated on April 6, 2026
HDFC Bank — Equity Research Report
Equity Research — Indian Banking
HDFC Bank
NSE: HDFCBANK  |  BSE: 500180  |  NYSE: HDB
ACCUMULATE
CMP
₹750.90 (as on 06 Apr 2026)
52-Wk High₹1,020.50
52-Wk Low₹726.65
Mkt Cap₹11.6L Cr
P/E (TTM)14.9×
P/B2.06×
Dividend Yield1.47%
Analysts (Buy)19 of 38
Target (Cons.)₹1,128
01 Business Overview

HDFC Bank is India’s largest private sector bank by assets and market capitalisation, and ranks among the world’s top-10 banks by market cap. Incorporated in 1994 and headquartered in Mumbai, it operates across four segments: Retail Banking, Wholesale Banking, Treasury, and Other Banking Operations. As of March 2025, the bank’s distribution network spanned 9,455 branches and 21,139 ATMs/CDMs across 4,160+ cities and towns, with 214,550 employees. The bank completed its transformative merger with parent HDFC Limited on 1 July 2023, making it a full-service universal bank with a combined balance sheet exceeding ₹39 lakh crore.

HDFC Bank commands roughly a 15% market share in total banking advances and a dominant 37% share of private-sector bank advances. It is designated one of India’s three Domestic Systemically Important Banks (D-SIBs), reflecting its critical role in the financial system. Key subsidiaries include HDFC Securities (broking), HDB Financial Services (NBFC), HDFC Life Insurance (50.2% stake), and HDFC ERGO General Insurance.

Balance Sheet
₹39L Cr+
FY25 consolidated
Branches
9,455
as of Mar 2025
Employees
2.15L
FY26 Q3
Private Bank Mkt Share
37%
advances, FY24
HDFC Merger
Jul ’23
Effective date
Credit Rating
AAA/A1+
CRISIL / ICRA
D-SIB Status
Yes
Systemically Important
ESG Score
80/100
S&P CSA (Low Risk)
02 Historical Financials

Post-merger financials from FY24 onwards are not directly comparable with pre-merger periods due to the consolidation of HDFC Ltd. The bank has demonstrated consistent profitability expansion despite elevated integration costs and a deliberate strategy of rebalancing its loan-to-deposit ratio.

Metric (₹ Cr) FY23 FY24 FY25 Q3 FY26
Net Interest Income85,5521,08,5321,14,17832,620
Net Revenue1,17,4531,57,7701,68,30045,870
Profit After Tax (Standalone)44,10960,81267,35018,654
EPS (₹ per share)58.679.892.8~24.4 (Q)
Book Value/Share (₹)538622681.9~700 est.
Gross NPA (%)1.171.241.331.24
Net NPA (%)0.270.330.430.42
NIM (total assets, %)4.13.43.353.35
CASA Ratio (%)~42~38~34~33
Dividend (₹/share)15.519.522.0—
Loan Growth YoY (%)17.055%*~7.011.9
Deposit Growth YoY (%)20.0—15.811.6

*FY24 loan growth inflated due to HDFC Ltd. merger consolidation. NIM contracted post-merger due to higher-cost housing book.

Q3 FY26 highlights: Standalone PAT ₹18,654 Cr (+11.5% YoY), NII ₹32,620 Cr (+6.4% YoY), Gross NPA improved to 1.24% from 1.42%, deposits up 11.6% YoY to ₹28.6L Cr.
03 DCF Valuation

For a bank, pure DCF on free cash flows is less standard; we use a Residual Income / P/B-based DCF framework anchored to excess ROE over cost of equity. Our model assumes normalised ROE of 16.5–17% by FY28 as merger integration benefits accrue, improving from a current ~13–14% trough. WACC: 12%, Terminal Growth: 5%.

DCF / Residual Income Valuation Model — 10-Year Horizon
16.5%
12.0%
5.0%
2.4×
₹770
−10%
Adjusted for current governance overhang; fair value pre-overhang ~₹1,050
₹940
↑ 25.2% Upside

Our base-case 1-year price target is set at ₹950, reflecting 2.2–2.4× FY27E book value — a modest discount to pre-merger multiples (3.0–3.5×) to account for governance uncertainty and slower-than-expected CASA recovery. Full re-rating to ₹1,100–1,200 is contingent on appointment of a credible permanent chairman and ROE improvement trajectory.

04 Buy Range
▲ BUY RANGE — Three Entry Zones
Strong Buy
≤ ₹720
Near 52-wk low; deep value. Aggressive accumulation zone. Margin of safety ~30%+ to base target.
Accumulate
₹720–₹820
Current CMP ₹750.90 falls here. Gradual SIP-style accumulation recommended. 20–25% upside to target.
Fair Value Entry
₹820–₹880
Add on dips within this band. P/B ~2.2× at top end. Near consensus fair value; limited margin of safety.
05 Buy Scenario Analysis
Bear Case — 1 Year
₹680
Governance crisis deepens. CEO succession uncertainty. NIM stays compressed at 3.2%. GNPA rises to 1.6%. Stock de-rates to 1.7× P/B. Further downside from current levels.
Base Case — 1 Year
₹950
New chairman appointed by mid-2026. Loan growth recovers to 12–14% in FY27. NIM stabilises at 3.4%. GNPA trending to 1.1%. P/B re-rates to 2.4×. 26% upside from CMP.
Bull Case — 1 Year
₹1,150
Governance resolved swiftly. ROE inflects to 16%+. Rate cuts boost NIM. CASA ratio recovers to 37–38%. Jefferies/JPMorgan targets approached. Significant re-rating.
06 Sell Range
▼ SELL / EXIT RANGE — Three Warning Zones
Reduce
₹1,050–₹1,150
Approaching analyst consensus targets. Book partial profits. Valuations full at 2.8–3.0× P/B.
Exit
₹1,150–₹1,250
Near Jefferies ₹1,240 target. P/B 3.0×+ for a bank with still-unresolved governance. Significant overvaluation risk.
Avoid New Entry
≥ ₹1,250
Historically rich valuations. Only justified if ROE recovers to 18%+. Risk-reward unattractive at these levels.
07 Sell Scenario Analysis
Overvalued Trigger
P/B exceeds 2.8× without ROE recovery
If stock rallies purely on sentiment without fundamental improvement in ROE, CASA, or NIM — reduce positions.
Exit Trigger
Governance escalates / CEO succession fails
If the chairman search drags beyond Oct 2026, or CEO Jagdishan’s reappointment is not approved by RBI, exit immediately.
Structural Break
GNPA > 1.8%, CASA < 30%, NIM < 3.1%
Combination of worsening asset quality, CASA erosion, and margin compression signals structural deterioration — full exit warranted.
08 Future Growth & Earnings Outlook

HDFC Bank is navigating a transitional phase post the HDFC Ltd. merger. The bank is deliberately moderating loan growth to bring its loan-to-deposit ratio (LDR) below 90% from near-100% levels — a conscious derisking strategy. Deposit mobilisation has been the priority, with average deposits growing 12–16% YoY across recent quarters. As this normalises, management expects loan growth to re-accelerate to 12–15% in FY27–28.

Loan Growth (FY27E)
12–14%
YoY, re-acceleration
NII Growth (FY27E)
10–12%
NIM stabilisation
PAT Growth (FY27E)
12–15%
Operating leverage kicking in
ROE (FY28E)
16–17%
vs current ~13.5%
EPS FY27E
₹110+
consensus estimate
Q4 FY26 Results
18 Apr
Board meeting date
HDB Fin. Services IPO
Pending
Potential value unlock
CASA Recovery Target
37–40%
FY27-28E, from ~33%

Rate cuts by the RBI (multiple cuts anticipated in 2026) are a double-edged sword — they ease deposit costs but also pressure loan yields. HDFC Bank’s predominantly floating-rate book means NIM expansion depends on deposit repricing happening faster than asset repricing. The pending HDB Financial Services IPO is a significant optionality, with the subsidiary valued at ₹60,000–80,000 crore in earlier estimates, unlocking shareholder value.

09 Risks & Catalysts
⚠ Active Governance Risk — Elevated Priority

Chairman Atanu Chakraborty resigned on 18 March 2026 citing practices “not in congruence with personal values and ethics.” The event was linked to (a) the Dubai DFSA regulatory restriction (Sep 2025) on onboarding new clients due to AT-1 bond mis-selling to NRI clients; (b) an eight-year delay in addressing compliance lapses; (c) suspected friction between the chairman and CEO Sashidhar Jagdishan over the CEO’s reappointment by RBI. The resignation wiped ~$21 billion in market value. Keki Mistry has been appointed interim chairman for 3 months. RBI has stated no material concerns on financial stability. Antique cut target to ₹1,090 from ₹1,200. Jefferies reiterated Buy at ₹1,240; JPMorgan upgraded to Overweight at ₹1,010.

▲ Catalysts / Bull Triggers
Swift appointment of credible permanent chairman — governance premium restored
RBI approves CEO Jagdishan’s reappointment; management continuity confirmed
Loan growth reacceleration to 14%+ as LDR normalises below 90%
NIM expansion as RBI rate cuts flow through; deposit cost repricing ahead
CASA ratio recovery to 37–38% from current ~33% trough
HDB Financial Services IPO — significant NAV unlock event
Moody’s projects 11–13% credit growth for Indian banks in FY26
Operating leverage: cost-to-income ratio improvement trajectory from ~44%
▼ Risks / Bear Triggers
Governance uncertainty extends — CEO tenure not renewed by RBI
AT-1 bond mis-selling investigation reveals deeper structural lapses
Dubai DFSA ban extended; reputational damage to NRI franchise
CASA ratio stays structurally depressed; funding cost disadvantage persists
NIM compression if deposit rate cuts lag or wholesale funding costs rise
Asset quality stress in unsecured retail and MSME book
Post-merger integration costs persist longer than expected
Stricter RBI norms on open FX positions affecting treasury income
10 Peer Comparison
Bank CMP (₹) Mkt Cap (₹Lcr) P/E (TTM) P/B GNPA (%) NIM (%) ROE (%) Rating
HDFC Bank750.9011.614.9×2.06×1.243.35~13.5Accumulate
ICICI Bank~1,190~8.418.4×~3.1×~2.0~4.3~17.5Buy
Kotak Mah. Bank~1,970~3.9~19×~3.2×~1.6~4.7~14.0Hold
Axis Bank~1,090~3.4~14.3×~1.9×~1.4~4.0~16.5Buy
SBI~795~7.1~10.8×~1.4×~2.1~3.2~14.0Buy
HDFC P/E Premium (vs peers)——At discount vs ICICI/KotakBelow historical 3–3.5×Best in classBelow ICICIAt troughContrarian

HDFC Bank historically traded at a 20–30% P/E premium over peers, justified by superior governance, franchise quality, and return ratios. Today, it trades at a discount to ICICI Bank and Kotak on P/E — a rare situation. The governance de-rating creates a contrarian opportunity, but re-rating requires visible triggers. ICICI Bank’s execution has been exemplary and currently commands justified premium. HDFC Bank’s case is fundamentally a ‘fallen aristocrat’ recovery thesis — strong underlying business, depressed multiple, binary governance resolution ahead.

Investment Verdict
A Premier Franchise at a Trough Valuation — But Patience Required
HDFC Bank’s core banking franchise remains unassailable — India’s largest private bank, dominant market share, best-in-class asset quality at 1.24% GNPA, and a post-merger balance sheet of exceptional scale. The stock has fallen 26% year-to-date and 16% over one year, creating what appears to be a valuation anomaly: a P/B of 2.06× for a bank that earned P/B 3.0–3.5× as recently as FY22. The governance crisis triggered by chairman Chakraborty’s abrupt resignation is a material near-term risk, but RBI’s reassurance and the interim appointment of Keki Mistry provide a stabilisation floor. For long-term investors with a 24–36 month horizon, CMP ₹750–820 represents an attractive accumulation zone. The base-case target of ₹950 offers ~26% upside; a bull-case resolution of governance issues could take the stock to ₹1,100–1,200. Key watchpoints: Q4 FY26 results (18 April 2026), permanent chairman appointment, and CEO reappointment by RBI.
ACCUMULATE
12-Month Price Target ₹950
Bull Case: ₹1,150
Bear Case: ₹680
DISCLAIMER: This report is prepared for informational and educational purposes only and does not constitute investment advice, a solicitation, or an offer to buy or sell securities. The author is not a SEBI-registered analyst or investment advisor. All data sourced from public filings, NSE/BSE, company presentations, and press reports as of 06 April 2026. Equity investments are subject to market risk. Past performance does not guarantee future results. Readers are advised to consult a SEBI-registered investment advisor before making any investment decisions. Figures marked “est.” or “E” are estimates and may differ from actual outcomes. The CMP of ₹750.90 is as of 02 April 2026 (last available close). Market prices change continuously. This report does not account for individual risk tolerance, tax considerations, or personal financial circumstances.

Tags:

HDFCPrivate Banks
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Buy vs Accumulate Rating in Stocks: Key Differences Every Investor Must Know

Recent Posts

  • HDFC Bank (NSE: HDFCBANK) — Stock Analysis April 2026
  • Buy vs Accumulate Rating in Stocks: Key Differences Every Investor Must Know
  • Persistent Systems Value Analysis April 2026
  • Infosys Ltd Share Value Analysis 2026
  • InterGlobe Aviation (INDIGO) — Deep Dive Share Analysis
Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS